Open Access
Frontiers in Molecular Biosciences, volume 6
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
Erik Henke
1
,
Rajender Nandigama
1
,
Süleyman Ergün
1
Publication type: Journal Article
Publication date: 2020-01-31
Journal:
Frontiers in Molecular Biosciences
scimago Q1
wos Q2
SJR: 1.232
CiteScore: 7.2
Impact factor: 3.9
ISSN: 2296889X
Biochemistry
Molecular Biology
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Abstract
Solid tumors are complex organ-like structures that consist not only of tumor cells but also of vasculature, extracellular matrix (ECM), stromal and immune cells. Often this tumor microenvironment (TME), comprises the larger part of the overall tumor mass. Like the other components of the TME the ECM in solid tumors differs significantly from that in normal organs. Intratumoral signaling, transport mechanisms, metabolisms, oxygenation, and immunogenicity are strongly affected if not controlled by the ECM. Exerting this regulatory control, the ECM does not only influence malignancy and growth of the tumor but also its response towards therapy. Understanding the particularities of the ECM in solid tumor is necessary to develop approaches to interfere with its negative effect. In this review, we will also highlight the current understanding of the physical, cellular and molecular mechanisms by which the pathological tumor ECM affects the efficiency of radio-, chemo- and immunotherapy. Finally, we will discuss the various strategies to target and modify the tumor ECM and how they could be utilized to improve response to therapy.
Found
Found
Top-30
Journals
10
20
30
40
50
60
|
|
Cancers
51 publications, 7.02%
|
|
Frontiers in Immunology
25 publications, 3.44%
|
|
International Journal of Molecular Sciences
19 publications, 2.62%
|
|
Frontiers in Oncology
17 publications, 2.34%
|
|
Scientific Reports
14 publications, 1.93%
|
|
Journal of Controlled Release
12 publications, 1.65%
|
|
Advanced healthcare materials
11 publications, 1.52%
|
|
Advanced Drug Delivery Reviews
9 publications, 1.24%
|
|
Cells
9 publications, 1.24%
|
|
Pharmaceutics
8 publications, 1.1%
|
|
Biomedicines
7 publications, 0.96%
|
|
Frontiers in Cell and Developmental Biology
7 publications, 0.96%
|
|
Molecular Pharmaceutics
6 publications, 0.83%
|
|
Frontiers in Bioengineering and Biotechnology
6 publications, 0.83%
|
|
PLoS ONE
6 publications, 0.83%
|
|
Biomedicine and Pharmacotherapy
6 publications, 0.83%
|
|
Frontiers in Molecular Biosciences
5 publications, 0.69%
|
|
Biomolecules
5 publications, 0.69%
|
|
Journal of Nanobiotechnology
5 publications, 0.69%
|
|
Acta Biomaterialia
5 publications, 0.69%
|
|
Advanced Science
5 publications, 0.69%
|
|
Journal of Experimental and Clinical Cancer Research
4 publications, 0.55%
|
|
Nature Communications
4 publications, 0.55%
|
|
Drug Delivery and Translational Research
4 publications, 0.55%
|
|
Cancer Cell International
4 publications, 0.55%
|
|
Matrix Biology
4 publications, 0.55%
|
|
Biomaterials
4 publications, 0.55%
|
|
Biochimica et Biophysica Acta - Reviews on Cancer
4 publications, 0.55%
|
|
Small
4 publications, 0.55%
|
|
10
20
30
40
50
60
|
Publishers
20
40
60
80
100
120
140
160
|
|
Elsevier
152 publications, 20.94%
|
|
MDPI
138 publications, 19.01%
|
|
Springer Nature
113 publications, 15.56%
|
|
Frontiers Media S.A.
75 publications, 10.33%
|
|
Wiley
72 publications, 9.92%
|
|
American Chemical Society (ACS)
27 publications, 3.72%
|
|
Cold Spring Harbor Laboratory
17 publications, 2.34%
|
|
Taylor & Francis
15 publications, 2.07%
|
|
American Association for Cancer Research (AACR)
9 publications, 1.24%
|
|
Royal Society of Chemistry (RSC)
7 publications, 0.96%
|
|
Bentham Science Publishers Ltd.
6 publications, 0.83%
|
|
Public Library of Science (PLoS)
6 publications, 0.83%
|
|
Hindawi Limited
5 publications, 0.69%
|
|
IOP Publishing
4 publications, 0.55%
|
|
SAGE
3 publications, 0.41%
|
|
Walter de Gruyter
3 publications, 0.41%
|
|
Oxford University Press
3 publications, 0.41%
|
|
BMJ
3 publications, 0.41%
|
|
AME Publishing Company
3 publications, 0.41%
|
|
Spandidos Publications
3 publications, 0.41%
|
|
American Society for Clinical Investigation
2 publications, 0.28%
|
|
Impact Journals
2 publications, 0.28%
|
|
Radiological Society of North America (RSNA)
2 publications, 0.28%
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 0.28%
|
|
Georg Thieme Verlag KG
2 publications, 0.28%
|
|
AIP Publishing
2 publications, 0.28%
|
|
American Physiological Society
2 publications, 0.28%
|
|
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 0.28%
|
|
American Association for the Advancement of Science (AAAS)
2 publications, 0.28%
|
|
20
40
60
80
100
120
140
160
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Henke E., Nandigama R., Ergün S. Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy // Frontiers in Molecular Biosciences. 2020. Vol. 6.
GOST all authors (up to 50)
Copy
Henke E., Nandigama R., Ergün S. Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy // Frontiers in Molecular Biosciences. 2020. Vol. 6.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3389/fmolb.2019.00160
UR - https://doi.org/10.3389/fmolb.2019.00160
TI - Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
T2 - Frontiers in Molecular Biosciences
AU - Henke, Erik
AU - Nandigama, Rajender
AU - Ergün, Süleyman
PY - 2020
DA - 2020/01/31
PB - Frontiers Media S.A.
VL - 6
SN - 2296-889X
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Henke,
author = {Erik Henke and Rajender Nandigama and Süleyman Ergün},
title = {Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy},
journal = {Frontiers in Molecular Biosciences},
year = {2020},
volume = {6},
publisher = {Frontiers Media S.A.},
month = {jan},
url = {https://doi.org/10.3389/fmolb.2019.00160},
doi = {10.3389/fmolb.2019.00160}
}
Found error?
Found error?
Publisher
scimago Q1
wos Q2
SJR
1.232
CiteScore
7.2
Impact factor
3.9
ISSN
2296889X
(Electronic)